Abstract:Multiple myeloma (MM) is a plasma cell cancer characterized by accumulation of malignant cells, preferentially in the bone marrow, that leads to severe bone disease in humans. This disease resulted in approximately 13,000 deaths last year in the United States. Caffeic acid phenethyl ester (CAPE), a phenolic compound found in bee glue, is reported to have an array of bioactive properties including anticancer effect. We previously reported that CAPE inhibits MM cell growth through induction of apoptosis and oxidative stress. It is established that iron oxide nanoparticles (IONPs) enhance drug delivery to tissues/cells and conjugation of a small peptide RGD with drug loaded IONPs improves cancer cell targeting. The purpose of this study is to improve the biocompatibility of CAPE through encapsulation onto IONPs (IONP/CAPE) and evaluate the cytotoxic and apoptogenic effects of IONP/CAPE with RGD conjugated as a targeting ligand for human MM cells. We hypothesize that RGD‐IONP/CAPE may enhance the intracellular delivery of CAPE to MM cells thus demonstrating more potent inhibition on the growth of MM cells than CAPE alone. We prepared RGD‐IONP/CAPE and characterized these NPs through determination of the hydrodynamic sizes and zeta potentials. We optimized the stability of these nanomaterial complexes with various stabilizers at different pH and evaluated the inhibitory effect of the most stable formulation on MM cell growth. Our results show that the developed RGD‐IONP/CAPE were stable at neutral and basic conditions, and subject to release of CAPE at acidic pH (5.5) in vitro. The RGD‐IONP/CAPE caused a decreased MM cell viability in a time (24, 48, 72 hours) and dose (1, 5, 10, 20 and 30 μM) ‐dependent manner. Interestingly, the growth‐inhibitory effects of RGD‐IONP/CAPE at 10 μM was equivalent to the parent drug at 30 μM, indicating a 3‐fold enhancement in CAPE delivery efficiency under the experimental condition. Apoptogenic effect of RGD‐IONP/CAPE was assessed using western blotting. Protein expression of apoptosis‐executioner caspase 3 was examined, and the results indicated that caspase 3 was activated. In conclusion, we constructed a novel CAPE‐loaded IONPs with RGD conjugation which showed more potent antimyeloma effect than parental CAPE.

Inhibition of Multiple Myeloma Using 5-Aza-2'-Deoxycytidine and Bortezomib-Loaded Self-Assembling Nanoparticles

Inducing Cell Cycle Arrest and Apoptosis by Dimercaptosuccinic Acid Modified Fe3O4 Magnetic Nanoparticles Combined with Nontoxic Concentration of Bortezomib and Gambogic Acid in RPMI-8226 Cells.

Nanodelivery of a Self-Assembling Prodrug with Exceptionally High Drug Loading Potentiates Chemotherapy Efficacy.

Encapsulation of Nano‐Bortezomib in Apoptotic Stem Cell‐Derived Vesicles for the Treatment of Multiple Myeloma

Melphalan-loaded Methoxy Poly(ethylene Glycol)-Poly(d,l-lactide) Copolymer Nanomicelles in the Treatment of Multiple Myeloma

Preparation of Caffeic Acid Phenethyl Ester‐incorporated Nanoparticles and Their Inhibitory Effects on Multiple Myeloma Cell Growth

Enhanced Precision Therapy of Multiple Myeloma Through Engineered Biomimetic Nanoparticles with Dual Targeting

N-Propionyl Polysialic Acid Precursor Enhances the Susceptibility of Multiple Myeloma to Antitumor Effect of Anti-Nprpsa Monoclonal Antibody.

Biomimetic Platelet Nanoparticles Encapsulated with Proteasome Inhibitor Bortezomib for Multiple Myeloma Treatment

Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138(-) CD34(-) tumor stem-like cells in multiple myeloma-bearing mice.

CD38-targeted and Erythrocyte Membrane Camouflaged Nanodrug Delivery System for Photothermal and Chemotherapy in Multiple Myeloma.

CD38-targeted and erythrocyte membrane camouflaged nano-drug delivery system for photothermal-chemotherapy in multiple myeloma

Nanoparticles Dual Targeting Both Myeloma Cells and Cancer-Associated Fibroblasts Simultaneously to Improve Multiple Myeloma Treatment

Encapsulation of Nano‐Bortezomib in Apoptotic Stem Cell‐Derived Vesicles for the Treatment of Multiple Myeloma (Small 40/2023)

Doxorubicin-Loaded PEG-CdTe Quantum Dots as a Smart Drug Delivery System for Extramedullary Multiple Myeloma Treatment

Nanoparticle delivery systems, general approaches, and their implementation in multiple myeloma

Hyaluronic Acid Shell and Disulfide-Crosslinked Core Micelles for in Vivo Targeted Delivery of Bortezomib for the Treatment of Multiple Myeloma.

BSA-AIE Nanoparticles with Boosted ROS Generation for Immunogenic Cell Death Immunotherapy of Multiple Myeloma

Fe 3 O 4 Nanoparticle Loaded Paclitaxel Induce Multiple Myeloma Apoptosis by Cell Cycle Arrest and Increase Cleavage of Caspases in Vitro

Gamma-Fe2O3 nanoparticles increase therapeutic efficacy of combination with paclitaxel and anti-ABCG2 monoclonal antibody on multiple myeloma cancer stem cells in mouse model.

Bortezomib-catechol Conjugated Prodrug Micelles: Combining Bone Targeting and Aryl Boronate-Based Ph-Responsive Drug Release for Cancer Bone-Metastasis Therapy